Press coverage about Clorox (NYSE:CLX) has been trending somewhat positive this week, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Clorox earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news articles about the company an impact score of 47.7365845459764 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of brokerages recently weighed in on CLX. ValuEngine upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Bank of America lowered their price objective on shares of Clorox from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Thursday, May 3rd. Citigroup lowered their price objective on shares of Clorox from $139.00 to $126.00 and set a “neutral” rating on the stock in a research report on Friday, May 4th. UBS Group began coverage on shares of Clorox in a research report on Wednesday, July 18th. They set a “sell” rating and a $110.00 price objective on the stock. Finally, Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, May 8th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. Clorox presently has an average rating of “Hold” and a consensus price target of $130.42.

CLX opened at $144.73 on Wednesday. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.67 and a current ratio of 1.09. Clorox has a 1-year low of $113.57 and a 1-year high of $150.40. The company has a market capitalization of $18.66 billion, a price-to-earnings ratio of 23.12, a price-to-earnings-growth ratio of 3.02 and a beta of 0.36.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.72 billion. During the same period last year, the firm earned $1.53 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. equities analysts anticipate that Clorox will post 6.41 EPS for the current year.

Clorox declared that its board has authorized a stock buyback program on Thursday, May 24th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 12.6% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

In other Clorox news, SVP Michael R. Costello sold 9,265 shares of the stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $140.02, for a total value of $1,297,285.30. Following the transaction, the senior vice president now directly owns 34,293 shares in the company, valued at $4,801,705.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.00% of the stock is currently owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Recommended Story: Diversification

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with's FREE daily email newsletter.